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There is no question that the risk of many cancers varies substantially by race, ethnic group, and gender. Although important clues to cancer etiology
may come from investigating the differences in risk across subgroups of the population, epidemiologic research has often focused on white men.
More descriptive and analytic studies are needed to identify and explain variations in risk among population subgroups. Especially important are
studies to clarify the role of differential exposures, susceptibility, and diagnostic factors in cancer incidence, although differences in treatment
may contribute to variations in cancer mortality. Improvements in classification of ethnicity, assessment of carcinogenic exposures in various
subpopulations, and measures of host susceptibility states should augment future epidemiologic research designed to better understand
mechanisms underlying the racial, ethnic, and gender differences in cancer risk. - Environ Health Perspect 103(Suppl 8):283-286 (1995)
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Introduction
Striking variations have been observed in
the incidence and mortality rates for cancer,
according to such factors as age, gender,
race, ethnicity, time, socioeconomic class,
marital status, and geographic location.
Descriptive studies, by uncovering the pat-
terns of cancers in populations, have
yielded many clues to cancer etiology. The
patterns are useful in monitoring variations
that might point to new environmental
hazards; in evaluating the effects of cancer
prevention, screening, and treatment activi-
ties; and in predicting future trends that
may help set priorities in cancer research.
This paper discusses issues relevant to
future epidemiologic research to clarify the
effects of race, ethnicity, and gender on the
riskofcancer.
Are the Variations Real
and Meaningful?
Variations in cancer risk often are remark-
able, even allowing for the fluctuation that
might be expected as a result ofchance and
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differences in diagnostic or reporting prac-
tices. Especially striking are variations by
racial group. Incidence rates among
African Americans are approximately 3
times higher for esophageal cancer, 2 times
higher for multiple myeloma, liver cancer,
cervical cancer, and stomach cancer, and
50% higher for cancers of the larynx,
prostate, oral cavity and pharynx, pancreas,
and lung than rates prevailing among
whites (1). However, compared with
whites, African Americans have a lower
incidence of melanoma and cancers of the
endometrium, thyroid, breast, bladder,
leukemia, lymphoma, ovary, testis, and
brain (1). Also well documented are gen-
der differences in cancer risks, with higher
rates generally among males, with some
exceptions such as the predominance of
cancers of the thyroid and gallbladder
among females (1). Ethnicity has been less
well studied in the United States, but is
also known to affect cancer risk. For exam-
ple, Hispanic subgroups, such as Cuban
Americans, Puerto Ricans, and Hispanics
from Central and South America, have can-
cer patterns that differ measurably from
those ofthe white non-Hispanic population
and from one another (2-7). Some data
suggest, however, that greater efforts are
needed to ensure precise designation ofrace
and ethnicity and thus enhance research on
ethnic differences in cancer risk (8,9).
Racial, ethnic, and gender differences in
cancer risk often vary by such factors as age,
geographic location, and tumor histologic
type. For example, white women are at
greater risk than African American women
for postmenopausal breast cancer, while
premenopausal breast cancer is more com-
mon amongAfrican Americans than whites
(10). Mortality rates for oral cancer among
women (but not men) are excessive in
southern rural parts ofthe country, primar-
ily because of the longstanding practice of
snuff dipping in this region (11). Esoph-
ageal cancers, the majority ofwhich are
squamous cell carcinomas, occur at much
higher rates amongAfrican Americans than
whites, whereas whites have a higher risk of
adenocarcinomas of the esophagus (12).
Thus, the influence ofage, geography, and
other demographic variables should be
considered, as well as cell type, to fully
evaluate variations in cancer risk among
special populations.
For some exposures and cancers, exten-
sive epidemiologic research has been con-
ducted based on cancer variations according
to race, ethnic background, and gender.
Examples include research on lung cancer
and tobacco use by race (13), the effects of
hormonal medications used by women
(14), and cancer and diet among different
ethnic groups (15). For many exposures,
however, research has focused primarily on
white men. For example, although women
and minorities account for 46 and 18%,
respectively, ofthe U.S. workforce, a survey
of 1233 published epidemiologic studies on
occupational cancer found only a few stud-
ies with in-depth analyses of risks among
white women (7%), nonwhite women (1%),
or nonwhite men (3%) (16). There were
legitimate reasons for exduding women and
minorities from some occupational studies,
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Table 1. Cancer mortality among male coke plant workers in the steel industry.
All cancers Lung cancer
% Employed White Nonwhite White Nonwhite
Work area White Nonwhite Obs Exp SMR (95% Cl) Obs Exp SMR (95% Cl) Obs Exp SMR (95% Cl) Obs Exp SMR (95% Cl)
Coke planta 100 100 199 193.8 103 (89-118) 121 106.7 113 (94-136) 11 12.2 90 (45-161) 26 9.6 271 (177-397)
Coke oven 42 91 80 80.2 100 (79-124) 104 92.9 112 (91-136) 8 4.7 170 (73-335) 23 7.6 303 (192-454)
Side 26 71 45 47.2 95 (70-128) 61 67.3 91 (69-116) 5 2.7 185 (60-432) 5 5.4 93 (30-216)
Partial topside 13 1 22 25.1 88 (55-133) 2 1.2 - - 2 1.6 - - 0 0.1 -
Full topside 3 19 13 7.8 167 (89-285) 41 24.4 168 (121-228) 1 0.5 - - 18 2.2 818 (485-1293)
Nonovena 58 9 119 113.6 105 (87-125) 17 13.8 123 (72-197) 3 7.3 41 (8-120) 1 1.2 -
Abbrevations: Obs, observed; Exp, expected; SMR, standardized mortality ratio; 95% Cl, 95% confidence interval. aCoke plant and nonoven data for lung cancer includes other
respiratory system cancers. From Lloyd (22).
such as the small number of subjects or
events, lower exposures, and difficulty in
tracing. There were some studies, however,
in which the data for women and minori-
ties could have been given more considera-
tion. Important clues to cancer etiology
may have been missed because of lack of
attention to groups other than white men.
More descriptive and analytic studies are
needed in epidemiologic research on cancer
to generate and test etiologic hypotheses
based on variations in cancer risk by racial,
gender, and ethnic subgroups.
What Accounts for the
Variations in Risk?
Racial, ethnic, and gender variations in
cancer risk may reflect differences in
environmental exposure or differences in
susceptibility and biologic response,
although some patterns may be due at least
partly to differences in diagnostic, report-
ing, and (in terms ofmortality) treatment
practices. Many of the racial and ethnic
patterns ofcancer risk are due at least partly
to socioeconomic differences (17-20).
Exposures
Some of the strongest evidence that envi-
ronmental exposures affect cancer patterns
across racial and ethnic groups comes from
observations of large international varia-
tions in risk and substantial changes in risk
among populations that have migrated
from one area of the world to another.
This was recently demonstrated in a study
ofAsian American migrants whose breast
cancer risk increased over several genera-
tions to attain rates prevailing in the U.S.
white population (21).
Differences in cancer risk among spe-
cial populations may reflect variations in
the intensity or duration of specific car-
cinogenic exposures. Among workers at a
coke plant within the steel industry, there
was almost a 3-fold increase in lung cancer
mortality among nonwhites (mainly
African Americans), whereas white workers
had a slightly lower than expected rate
(Table 1) (22). Examination ofwork areas
within the coke plant revealed that 91% of
nonwhites but only 42% of whites were
employed near the coke oven, particularly
at the top side of the ovens, where there
was heavy exposure to the by-products of
coal carbonization. The elevated risk of
lung cancer among nonwhites in the coke
plant thus simply reflects their work assign-
ments and exposures rather than a racial
differential in susceptibility. This study
illustrates the importance of detailed job
titles and exposure assessment in identify-
ing racial differences in cancer risk as well
as the risk factors involved. Ifonly broad
occupational categories were used, an
important occupational carcinogen would
have been missed.
Tobacco smoking explains some ofthe
gender and racial differences in cancer risk.
For example, a large case-control study of
oral and pharyngeal cancer in the United
States showed that variation in the preva-
lence of use and the risks associated with
tobacco and alcohol accounts for much of
the higher incidence among men than
women and amongAfrican Americans than
whites (23). Detailed information on the
amounts oftobacco and alcohol consumed
helped clarify their role in the etiology of
these tumors. Similarly, the role ofdiet in
the etiology ofcancer may be better under-
stood if differences in portion sizes con-
sumed by men and women are considered
along with qualitative patterns in dietary
and nutritional habits. In general, refine-
ments in the assessment of lifestyle and
other environmental exposures will allow
more accurate comparison of risks across
subgroups ofthe population.
Biologic Response
On the other hand, there is evidence that
subgroups of the population may experi-
ence different cancer risks, even when types
and levels ofvarious exposures are precisely
defined. In a recent study ofesophageal can-
cer, Brown et al. (24) found that after de-
tailed controlling for amount of smoking
and alcohol consumption, the odds ratios
associated with these exposures were sub-
stantially greater among African Americans
than whites (Table 2). At each exposure
level, African Americans had estimated
annual incidence rates about 3 to 9 times
higher than those for whites. Although the
racial differences in risk may be due to dif-
ferences in the types ofalcohol consumed
or to dietary and other exposures that



















1.8 (0.5-6.1) 5.7 (2.0-15.8)
4.6 (1.7-12.8) 10.6 (4.1-27.2)
19.7 (7.2-53.4) 39.5 (14.5-107.8)









Heavy 0-7 3.3 (1.0-10.8) 4.5 (1.4-14.6) 1.6 6.3
Heavy 8-14 8.7 (2.4-32.4) 14.2 (4.1-49.1) 4.4 19.9
Heavy 15-35 22.1 (7.8-62.3) 36.8 (13.9-97.2) 11.0 51.5
Heavy 36-84 28.5 (10.1-80.2) 42.1 (15.8-112.6) 14.2 58.9
Heavy .85 35.4 (10.0-125.5) 149.2 (39.2-567.4) 17.7 208.9
aOdds ratios (95% confidence intervals) are adjusted for age, geographic area, and income. From Brown (24).
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interact with alcohol or tobacco, the
findings raise the possibility of racial dis-
parity in a susceptibility factor that remains
to be identified. The esophageal cancer
study is part of a large National Cancer
Institute multicancer case-control study
designed to shed light on the racial differ-
ences in rates of multiple myeloma and
cancers ofthe prostate, esophagus, and pan-
creas, which occur at higher rates among
African Americans than amongwhites.
There also is some suggestion that lung
cancer risk mayvary bygender (25,26) and
ethnicity (27) even after controlling for
level ofsmoking. Other risk factors, such as
diet or inborn susceptibility, may be
responsible. The high rates ofthyroid and
gallbladder cancers among women have led
to studies suggesting the importance of
reproductive and hormonal factors in the
development ofthese tumors (28,29).
In a search for susceptibility states that
may vary demographically, recent research
has centered on pharmacogenetic studies;
notably, the possible role ofthe P450 family
ofgenes, whose polymorphic expression
may affect the metabolism ofcarcinogens,
either by activation or detoxification. Table
3 presents some genetic polymorphisms that
vary by race and affect the metabolism of
occupational carcinogens. For example, the
CYPJAJ gene that influences metabolism of
polycyclic aromatic hydrocarbons shows
polymorphic variation among whites,
Table 3. Examples of genetic polymorphisms of meta-
bolic enzyme activity thatvary by race.
Gene Occupational carcinogen
CYP1A1 Polycyclic aromatic hydrocarbons
CYP2A1 Aromatic amines
CYP2D6 Polycyclic aromatic hydrocarbons
CYP2E1 Benzene, butadiene
NAT2 Aromatic amines
Asians, and African Americans (30-33).
There is also a different pattern ofmuta-
tions among Asians and Caucasians for N-
acetyltransferase (NAT2), which plays a role
in the metabolism ofaromatic amines that
are bladder carcinogens (34,35). Studies
conducted in Japan, China, Italy, and
Arkansas have shown racial differences in
the activity of CYPIA2, which is involved in
the metabolic activation ofaromatic amines,
heterocyclic amines, and other carcinogens
(36,37). Future studies on head and neck
cancers might focus on CYP2EJ, since it is
inducible by ethanol and also participates in
the activation ofcertain nitrosamines.
Diagnosis andTreatment
For cancer incidence and to a greater extent
mortality, some differentials in risk may
reflect access to health care. Cancer screen-
ing, stage at diagnosis, and treatment prac-
tices varyacross subgroups ofthe population
and affect rates ofcancer detection and sur-
vival (38-44). For example, African Amer-
ican and Hispanic women are less likely to
undergo mammography than non-Hispanic
white women (38,40,41). Minorities are
more likely than white women to be diag-
nosed with advanced stages of the disease
(41,44-46). Accounting for socioeconomic
factors lessens but does not eliminate the
observed racial and ethnic differences in
stage at diagnosis and survival (45-47).
These factors should be kept in mind when
drawing etiologic inferences from the
demographic patterns in cancer incidence
and mortality.
Recommendations
In future epidemiologic research on avoid-
able causes of cancer, it is important that
we not overlook opportunities to evaluate
cancer risk among women and minorities.
Immediate attention should be given to
data already collected but not yet analyzed.
The National Cancer Institute's program
to fund small grants for further analyses of
existing data sets should help fill the gaps
in our understanding ofthe distribution of
cancer among various subgroups of the
population and the causes ofthe differen-
tial risks. In addition, all new data resources
should include, whenever possible, a diver-
sity of population subgroups. At the
National Cancer Institute, the Surveillance,
Epidemiology and End Results (SEER)
Program ofpopulation-based cancer reg-
istries recently expanded its coverage of
minorities by adding registries from Los
Angeles and northern California, where
large populations of Hispanics and Asian
Americans are located (48).
Suggestions are occasionally made to
remove information on race from data sys-
tems to avoid discrimination. In fact,
inclusion of race allows monitoring to
detect disparities that point to avoidable
hazards and medical inequities. In addi-
tion, we need to improve exposure assess-
ment, with special attention to potential
differences among women and minorities.
Specialized methods may be needed to
assess lifestyle and other environmental
exposures across subgroups ofthe popula-
tion. Finally, biological markers of expo-
sure and susceptibility states should be
incorporated into epidemiologic studies
whenever possible, remembering that nor-
mal values for white men may not be
applicable to other segments ofthe popula-
tion. As has happened in the past, future
research that encompasses women and
minorities may yield new insights into car-
cinogenesis that should eventually enhance
the prospects for cancer prevention in the
entire population.
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